Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Non-specific bacterial and cutaneous cellular components refers to a broad range of biological molecules, including proteins, lipids, and nucleic acids, that are targeted by non-selective antimicrobial agents (DrugBank DB09096). These agents, such as benzoyl peroxide and hydrogen peroxide, do not bind to a specific receptor but instead act through the release of reactive oxygen species or other oxidative mechanisms that denature proteins and disrupt cell membranes (StatPearls NBK507814). This non-specific action is effective against a wide spectrum of bacteria, making it useful in treating conditions like acne vulgaris and preventing wound infections (PubMed PMID: 22359483). However, the lack of specificity means that host cells, such as keratinocytes and fibroblasts, can also be damaged, potentially leading to skin irritation or delayed healing (PubChem CID: 784). This classification is typically used in pharmacology to describe the multi-faceted, non-targeted impact of topical antiseptics and disinfectants. By attacking multiple cellular components simultaneously, these drugs minimize the risk of bacterial resistance development compared to site-specific antibiotics. Consequently, they remain a cornerstone of dermatological therapy and surgical site preparation.
Non-specific oxidation of proteins, lipids, and nucleic acids; disruption of cell membranes; and denaturation of cellular proteins.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-specific bacterial and cutaneous cellular components.